Chemed Corp banner

Chemed Corp
NYSE:CHE

Watchlist Manager
Chemed Corp Logo
Chemed Corp
NYSE:CHE
Watchlist
Price: 422.72 USD 0.38% Market Closed
Market Cap: $5.8B

P/OCF

14.9
Current
36%
Cheaper
vs 3-y average of 23.5

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
14.9
=
Market Cap
$5.3B
/
Operating Cash Flow
$388.3m

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
14.9
=
Market Cap
$5.3B
/
Operating Cash Flow
$388.3m

Valuation Scenarios

Chemed Corp is trading below its 3-year average

If P/OCF returns to its 3-Year Average (23.5), the stock would be worth $664.41 (57% upside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-11%
Maximum Upside
+57%
Average Upside
27%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 14.9 $422.72
0%
3-Year Average 23.5 $664.41
+57%
5-Year Average 22.9 $647.55
+53%
Industry Average 16.1 $455
+8%
Country Average 13.3 $377.73
-11%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close
Market Cap P/OCF P/E
US
Chemed Corp
NYSE:CHE
5.8B USD 14.9 21.9
US
CVS Health Corp
NYSE:CVS
99.6B USD 9.4 56.3
US
Cigna Group
XMUN:CGN
69.3B EUR 8.3 13.4
US
Cigna Corp
NYSE:CI
74.4B USD 0 12.5
DE
Fresenius Medical Care AG
XMUN:FME
22.8B EUR 8.5 23.3
DE
Fresenius SE & Co KGaA
XETRA:FRE
22.7B EUR 8.8 18
US
Quest Diagnostics Inc
NYSE:DGX
21.8B USD 11.8 21.4
US
Laboratory Corporation of America Holdings
NYSE:LH
21.7B USD 13.2 24.7
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR 4 11.1
US
Guardant Health Inc
NASDAQ:GH
11.6B USD -62.6 -27.8
US
DaVita Inc
NYSE:DVA
10.3B USD 5.5 13.8

Market Distribution

In line with most companies in the United States of America
Percentile
56th
Based on 9 488 companies
56th percentile
14.9
Low
0 — 8.8
Typical Range
8.8 — 20.1
High
20.1 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 8.8
Median 13.3
70th Percentile 20.1
Max 3 188 432.5

Chemed Corp
Glance View

Chemed Corporation, a somewhat enigmatic yet resolutely steadfast entity, operates in the realms of hospice care and plumbing services, a duality that intrigues analysts and investors alike. Established through strategic foresight, Chemed has crafted a remarkably resilient business model by housing two distinct subsidiaries under its corporate umbrella: VITAS Healthcare and Roto-Rooter. VITAS Healthcare, which still stands as the nation's largest provider of end-of-life care, dominates the hospice sector by offering comprehensive palliative care services right at the patients' doorstep, aiming to ensure dignity and comfort during life's final stages. This subsidiary capitalizes on a combination of Medicare and Medicaid reimbursements as well as private insurances, which form the backbone of its revenue stream. Meanwhile, Roto-Rooter, a company with a name synonymous with plumbing repair and maintenance, fortifies Chemed's revenue streams through an entirely different channel. Known as a household name across America, Roto-Rooter offers an extensive range of services from emergency plumbing repair to water cleanup and restoration. With its franchise model combined with company-operated branches, Roto-Rooter generates income primarily through service fees. The dual nature of Chemed’s operational style—a blend of healthcare sensitivity and industrial pragmatism—not only ensures diversified income avenues but also exemplifies a pragmatic approach to risk management. This business strategy, deftly combining distinct yet robust sectors, allows Chemed to weather economic fluctuations that might impact one industry but not the other, ultimately creating a stable financial foundation for the company.

CHE Intrinsic Value
485.51 USD
Undervaluation 13%
Intrinsic Value
Price $422.72
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett